Notice of Certification and Settlement Approval Hearing (Press) CALGARY, AB, Jan. /CNW/ – A class action, Tluchak (Estate) v Bayer Inc., QBG-RG-00517-2016, commenced in the ...

Johnson & Johnson ( JNJ) Q4 2025 Earnings Call January 21, 2026 8:30 AM EST Good morning, and welcome to Johnson & Johnson's Fourth Quarter 2025 Earnings Conference Call. [Operator Instructions] This ...

Detailed price information for Regeneron Pharmaceuticals (REGN-Q) from The Globe and Mail including charting and trades.

Pharmaceutical companies have raised prices on hundreds of drugs so far this month despite federal efforts to rein in drug ...

BAYRY jumps 6.6% after partner Orion said Nubeqa sales tied to Bayer could top ???1B long term. Bayer also announced pharma ...

Secondary US filings for Bayer assets cannot be relied on again to face future patent cliffs, demanding focus on early-stage ...

7 January 2026 As he hands over the baton, Bobby Mukherjee reflects on his time leading the Chartered Institute of Patent ...

German pharma giant Bayer AG BAYRY has entered into a collaboration and global licensing agreement with Soufflé Therapeutics to develop a heart-targeted small interfering RNA (siRNA) therapy in a move ...

In early January 2026, Bayer’s subsidiaries and partners reported a series of R&D advances, including FDA acceptance of AskBio’s IND for AB-1009 gene therapy for late-onset Pompe disease with Fast ...

TrumpRx is supposed to launch in early 2026. Here's what we know about how buying medicine through the site to get discounts on prescription drugs will work ...

Drug developers secured approvals for 46 new therapeutic agents from the FDA’s Center for Drug Evaluation and Research (CDER) in 2025. This cohort brings the 5-year average down a touch, to 48 new ...

2025 has proved to be a turnaround for the German pharmaceutical giant Bayer BAYRY. Shares have skyrocketed 121.6% over the past year compared with the industry’s gain of 19.2%. The stock has also ...